What is Biotest's current dividend yield, its reliability and sustainability?
0.20%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: BIO3's dividend (0.2%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.34%).
High Dividend: BIO3's dividend (0.2%) is low compared to the top 25% of dividend payers in the German market (3.63%).
Stability and Growth of Payments
Stable Dividend: BIO3 is not paying a notable dividend for the German market, therefore no need to check if payments are stable.
Growing Dividend: BIO3 is not paying a notable dividend for the German market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: BIO3 is not paying a notable dividend for the German market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of BIO3's dividend in 3 years as they are not forecast to pay a notable one for the German market.
What is the CEO of Biotest's salary, the management and board of directors tenure and is there insider trading?
4.3yrs
Average management tenure
CEO
MichaelRamroth(58yo)
0.6yrs
Tenure
€1,012,000
Compensation
Dr. Michael Ramroth serves as Chairman of the Management Board and CEO at Biotest Aktiengesellschaft since May 01, 2019. Dr. Ramroth serves as Chief Financial Officer at Biotest Aktiengesellschaft. He serv ...
CEO Compensation Analysis
Compensation vs Market: Michael's total compensation ($USD1.13M) is about average for companies of similar size in the German market ($USD1.22M).
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
Management Age and Tenure
4.3yrs
Average Tenure
Experienced Management: BIO3's management team is considered experienced (4.3 years average tenure).
Board Age and Tenure
8.3yrs
Average Tenure
Experienced Board: BIO3's board of directors are considered experienced (8.3 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Management Team
Michael Ramroth (58yo)
Chairman of the Management Board
Tenure: 0.6yrs
Compensation: €1.01m
Peter Seith
Head of Quality Operations
Tenure: 0yrs
Georg Floß
COO & Member of the Board of Management
Tenure: 6.9yrs
Compensation: €888.00k
Monika Buttkereit
Head of Investor Relations
Tenure: 0yrs
Christina Erb
Head of Corporate HR
Tenure: 4.3yrs
Katrin Bernöster
Head of the Project Management Organisation
Tenure: 0yrs
Jörg Schüttrumpf
Head of Research & Development
Tenure: 0yrs
Wolfgang Möller
Head of Development - Plasma Protein
Tenure: 0yrs
Hermann Keuper
Senior Vice President of Manufacturing
Tenure: 0yrs
Board Members
Kerstin Birkhahn
Member of Supervisory Board
Tenure: 9.7yrs
Compensation: €34.00k
Rolf Hoffmann (60yo)
Chairman of the Supervisory Board
Tenure: 0yrs
Cathrin Schleussner
Member of the Supervisory Board
Tenure: 8.4yrs
Compensation: €37.00k
Jurgen Heilmann
Member of Supervisory Board
Tenure: 8.3yrs
Compensation: €34.00k
Tan Yang
Deputy Chairman of Supervisory Board
Tenure: 0yrs
Compensation: €50.00k
Christine Kreidl
Supervisory Board member
Tenure: 2.3yrs
Compensation: €47.00k
Company Information
Biotest Aktiengesellschaft's company bio, employee growth, exchange listings and data sources
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through Therapy, Plasma & Services, and Othe ...
Company Analysis and Financial Data Status
All financial data provided by Standard & Poor's Capital IQ.
Data
Last Updated (UTC time)
Company Analysis
2019/12/12 21:00
End of Day Share Price
2019/12/12 00:00
Earnings
2019/09/30
Annual Earnings
2018/12/31
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.